Proteomic profiling of lymphedema development in mouse model.

Area of Science:

• Proteomics
• Vascular Biology
• Biochemistry

Background:

• Lymphedema is a chronic condition characterized by lymphatic fluid retention, impacting tissue fluid homeostasis.
• Current prevention and treatment methods for lymphedema remain limited, despite a growing understanding of the disease.
• The lymphatic vascular system is crucial for maintaining fluid balance within tissues.

Purpose of the Study:

• To investigate differential protein expression in a mouse model of lymphedema.
• To identify potential protein biomarkers and therapeutic targets for lymphedema.
• To compare protein profiles between lymphedema-induced and sham-operated control mice.

Main Methods:

• Utilized two-dimensional gel electrophoresis (2-DE) and mass spectrometry to analyze protein expression.
• Induced lymphedema in the right hindlimb of male ICR mice.
• Validated proteomics findings using Western blotting analysis.

Main Results:

• Identified twenty differentially expressed functional proteins between lymphedema and normal tissues.
• Observed differential upregulation of specific proteins, including apolipoprotein A-1 preprotein, parkinson disease, and serum amyloid P-component precursor, in lymphedema mice.
• Confirmed upregulation of serum amyloid P-component precursor, parkinson disease, and apolipoprotein A-1 preprotein via Western blotting.

Conclusions:

• The study identified several upregulated proteins in a lymphedema mouse model, suggesting their involvement in the disease's pathophysiology.
• Upregulated proteins such as serum amyloid P-component precursor, parkinson disease, and apolipoprotein A-1 preprotein represent potential targets for lymphedema treatment.
• These findings provide valuable insights into the molecular mechanisms underlying lymphedema.